Nustasium 50 mg tabl. 20

Nustasium 20 tabl

.

Therapeutic Indications:

Nustasium is indicated as a temporary or occasional tool for action to promote sleep.

Composition:

hydrochloridum Diphenhydramine (DCI) 50 mg - Lactosum - Maydis amylum - Gelatinum - colloidal silicon. - Acidum alginicum - talcum - Magnesii stearas qs pro comp tablet. uno.

Pharmaceutical form:

Divisible tablets for oral use containing 50 mg of Diphenhydramine hydrochloridum.

Posology and method of administration:

Adults and adolescents from 16 years: 1 tablet 20 minutes before bedtime.

This is a medicine, no prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.

Contraindications:

related to the anticholinergic effect: - Glaucoma by closing the corner - Risk of urinary retention due to urethral and prostate disorders - Hypersensitivity to diphenhydramine - Asthma attack - Stenosis Left peptic ulcer - pyloroduodenal obstruction.
Children younger than 16 years.

Special precautions:

The attention of the patient should be specifically drawn to the risk of daytime sleepiness due to the sedative effect of diphenhydramine.
Caution is advised in elderly people because of a possible sedative effect, the risks of ocular hypertension and prostate problems encountered few are symptomatic.
As with all means at the central nervous system depressants, the intake of alcoholic beverages during the treatment, not recommended.
Myasthenia gravis.

Use during pregnancy and breastfeeding:

Pregnancy.
The prescription is not recommended during pregnancy and in particular during the first three months and at the end of pregnancy because of possible drowsiness and hypersensitivity of the central nervous system of the newborn.
Breastfeeding.
Use is not recommended during breastfeeding.

Undesirable effects:

Because of the strong sedative activity of diphenhydramine, may occur daytime sleepiness. One should therefore take into account when driving or operating machinery.
Anticholinergic effects: dry mouth, accommodation disorders, constipation, urinary retention, confusion or agitation in the elderly.
Gastrointestinal disorders: nausea, vomiting, diarrhea or constipation, abdominal pain.
Rare: certain types of dyskinesia were described after prolonged administration of antihistamines.
Leukopenia, agranulocytosis in rare cases.

Effect on driving and using machines:

The sedative effects of diphenhydramine, the patient is unfit order to drive and / or machines.

Overdose:

Children: The dominant symptoms include excitation with agitation, hallucinations, ataxia, coordination disorders, convulsions and Athetosis. Metintervallen the following symptoms: trembling and dilation of pupils, redness of the tegumenten (face) and hyperthermia are frequent signs that indicate an atropine intoxication. The terminal phase is accompanied by coma, which worsens in a cardiorespiratory collapsus. Death can occur within a span of 2 to 96 hours.
In infants and young children: The accidental ingestion by children and infants can lead to respiratory disorders that are sometimes fatal.
In adults: The picture is different: depression and coma may precede a phase excitation and convulsions. Fever and redness of the tegumenten are rare.
Treatment: It is symptomatic and by administration of activated charcoal to bind to diphenhydramine in the intestinal tract, possibly assisted or artificial respiration and administration of anticonvulsants.

Interactions:

Taking into account the additive atropine-like effect in case of an association with other anticholinergics (other antihistamines, neuroleptics, anticholinergic anti-Parkinson agents, atropine-like antispasmodic, disopyramide, tricyclic antidepressants).
Potentialisering resources of the central nervous system depressants (hypnotics, anesthetics, alcohol).
diphenhydramine will not be prescribed with monoamine oxidase inhibitors (MAO inhibitors) because of an increased effect.

Major incompatibilities:

There are no known incompatibilities.